BIOTAILOR ILAC SANAYI VE TICARET ANONIM SIRKETI – Trademark Portfolio

Entity Type: 99

BIOTAILOR ILAC SANAYI VE TICARET ANONIM SIRKETI holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include DR. AMINO ACID.

Sanayi Mahallesi Teknopark Bulvari

Teknopark Istanbul Sit. No:1/1; Pendik;

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

BIOTAILOR ILAC SANAYI VE TICARET ANONIM SIRKETI's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does BIOTAILOR ILAC SANAYI VE TICARET ANONIM SIRKETI have?

BIOTAILOR ILAC SANAYI VE TICARET ANONIM SIRKETI has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does BIOTAILOR ILAC SANAYI VE TICARET ANONIM SIRKETI file in?

BIOTAILOR ILAC SANAYI VE TICARET ANONIM SIRKETI files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are BIOTAILOR ILAC SANAYI VE TICARET ANONIM SIRKETI's most well-known trademarks?

BIOTAILOR ILAC SANAYI VE TICARET ANONIM SIRKETI's registered trademark portfolio includes well-known marks such as DR. AMINO ACID. These are among 1 currently registered trademark in the portfolio.

What is BIOTAILOR ILAC SANAYI VE TICARET ANONIM SIRKETI's trademark registration success rate?

BIOTAILOR ILAC SANAYI VE TICARET ANONIM SIRKETI has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.